Uterine cancer, or endometrial cancer, is a silent yet formidable foe that affects the female reproductive system. While it may not receive the same public attention as some other cancers, its impact can be profound, and understanding its nature is crucial for early detection and management.
The uterine tumour is a type of cancer that originates in the uterus, the hollow, pear-shaped organ in a woman's pelvis where a foetus develops during pregnancy. The most common variety of uterine cancer is endometrial cancer (cancer of the uterine lining), which develops in the endometrium (inner lining of the uterus). While it is primarily a disease of older women, it can also affect younger individuals, making it a concern for all women. Early detection significantly improves prognosis and survival rates.
The early symptoms of endometrial cancer can be subtle and often go unnoticed, which is why it is sometimes referred to as the "silent killer." However, some common symptoms are:
Unfortunately, these symptoms can be easily overlooked or attributed to other medical conditions, delaying the endometrial cancer diagnosis.
The exact reason for uterus cancer is not entirely known, but several risk factors have been recognised. These include:
Uterine cancer, if left untreated or undetected, can result in various complications that can significantly impact a woman's health and well-being. These complications may include:
Uterine cancer often manifests with subtle symptoms, making it difficult to detect in its early stages. When a woman experiences persistent or unusual vaginal bleeding, it is crucial to seek medical assistance promptly. A doctor will typically perform a pelvic examination and may conduct additional evaluations for uterine cancer detection, such as an ultrasound, biopsy, or endometrial sampling, to confirm the diagnosis. These diagnostic methods can provide valuable information about the cancer's size, location, and stage, which is essential for determining the appropriate treatment plan.
The treatment and management of the cancer depend on the stage and type of endometrial cancer and the patient's overall wellness and personal preferences.
In the initial stages, surgery is often the primary treatment to remove the cancerous tissue and prevent the spread of the disease. Surgery may involve a hysterectomy, which is the surgical removal of the whole uterus and, in some cases, one or both fallopian tubes and ovaries as well.
For more advanced or aggressive forms of uterine cancer, a combination of treatments may be necessary. Radiotherapy, which uses high-energy waves to destroy cancer cells, may be used before or after surgery to enhance the effectiveness of the treatment. Chemotherapy, which includes the use of powerful drugs to kill rapidly dividing cancer cells, may also be prescribed to target remaining cancer cells or to prevent the disease from spreading.
In recent years, advancements in targeted therapies have provided new hope for patients with uterine cancer. These innovative treatments target specific molecular pathways involved in the growth and spread of cancer cells. They can be used with traditional therapies or as a standalone option for patients who may not be eligible for surgery or other conventional treatments.
Steps that women can take to reduce their risk of uterine cancer, include:
Women should proactively monitor their gynaecological health and seek medical attention if they experience unusual or persistent symptoms. It is significant for those with known risk factors for uterine cancer, such as a family history of the disease or a history of endometrial hyperplasia, a precancerous condition that can lead to uterine cancer.
If a woman notices any changes in her menstrual cycle, experiences unexpected vaginal bleeding, or feels pelvic discomfort or pain. In that case, scheduling an appointment with a doctor as soon as possible is crucial.
The most common warning sign of uterine or endometrial cancer is unusual vaginal bleeding or spotting, which may occur between menstrual cycles or after menopause. Other symptoms may include pelvic pressure or pain, difficulty urinating, and unexplained weight loss.
Uterine cancer is generally a highly treatable form of cancer, especially when detected and treated in the early stages. With prompt and appropriate treatment, many women with uterine cancer can achieve long-term remission or even a complete cure.
Uterine cancer may not cause significant pain in its early stages, as the disease can often progress without producing noticeable symptoms. However, as the cancer advances, it may cause pelvic pain, cramping or discomfort. The level of pain can vary and depend on the stage and location of the tumour.
The rate at which uterine cancer spreads can differ and depend on the type and stage of the disease. In general, uterine cancer is considered a relatively slow-growing cancer, and it may take several years for the disease to spread to other organs or tissues. However, in some cases, particularly with more aggressive subtypes, the cancer can spread more rapidly.
Endometrial cancer is the most common variety of uterine cancer and is typically diagnosed in women between the ages of 50 and 70. The risk of developing endometrial cancer rises with age, with the majority of cases occurring in postmenopausal women.
When discussing uterine cancer with your doctor, consider asking the following questions: